InvestorsHub Logo
Followers 785
Posts 38604
Boards Moderated 9
Alias Born 06/20/2009

Re: None

Monday, 04/04/2022 9:48:40 AM

Monday, April 04, 2022 9:48:40 AM

Post# of 64116
Answer by TimGDixon » Mon Apr 04, 2022 2:05 am

UM is not being paid 200 million anything. Below is the payment schedule. Yes the first 200k was paid and IND paperwork completed.

Item 1.01 Entry into a Material Definitive Agreement.

On March 24, 2022, Office of Technology Transfer, University of Miami, and Therapeutic Solutions International, Inc. entered into an Asset Transfer and License Agreement. The material information relevant to public disclosure is the following: Within ten (10) days of the Effective Date, 1) TSOI shall make an initial payment of two hundred thousand dollars ($200,000) to UM; 2) Within six (6) months of the Effective Date, TSOI shall make a second payment of one million eight hundred thousand dollars ($1,800,000) (at the completion of the primary endpoint of the phase 2b/3 clinical trial specified in the IND or (ii) one (1) year from the Effective Date), and 3) TSOI shall make a final payment of two million dollars ($2,000,000). In turn TSOI replaces UM as Sponsor, receives all trial doses, and appoints James Veltmeyer, MD, Chief Medical Officer as Principal Investigator.

Question by A2Z » Sun Apr 03, 2022 10:34 am

Tim correct me if i am wrong.... by you paying the 200 million to UM was the one last thing you claimed you were working on to get the eua where you could submit it.

I know you came back and clarified that fda has to approve um deal and that all has been submited on phase 3 of it. now do you have opinion of how long it will take the fda to approve it so phase 3 can start.

https://forum.therapeuticsolutionsint.com/viewtopic.php?p=453&hilit=blah#p453


Alpha Male always Caribbean Wolf Pack Strong The Society of Slayers...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News